We are thought leaders in comparative effectiveness research (CER) and patient-centered outcomes research (PCOR). Read More
CMTP focuses on novel efforts in research standards, research infrastructure, and policy. Read More
Stay up to date with the latest CMTP news and industry happenings. Read More
CMTP is strongly committed to the creation of public-private partnerships. Read More
Browse industry research, articles, publications and other important resources by topic or content type. Read More
View All
This document reports on a project conducted by the Center for Medical Technology Policy 's Green Park Collaborative to create multi-stakeholder vetted recommendations for the design of studies in later phases of drug development to evaluate the ability of disease-modifying agents to delay or prevent the onset of dementia due to Alzheimer 's disease.
An evaluation of the GPC's pilot project, which resulted in an EGD on the study of therapies for Alzheimer's disease.
This EGD on Alzheimer's disease tests a process for developing disease-specific guidance for clinical studies that meet the needs of both payers and health technology assessment bodies.